The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market.

1. Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid
Viscosupplementation
Report Summary
The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by
2017. The hyaluronic acid viscosupplementation segment is expected to constitute the
majority of the Asia-Pacific orthopedic biomaterials market.
Buy Now: Asia Pacific Markets for Orthopedic Biomaterials
Browse All: Latest Market Research Reports
The Asia-Pacific orthopedic biomaterials report covers the following countries:
Japan
South Korea
Australia
China
The segments covered in this report include:
autologous bone grafts,
bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and
synthetics),
hyaluronic acid (HA) viscosupplementation,
bone morphogenetic protein (BMP) growth factor therapy
autologous chondrocyte implantation (ACI)
The market is approaching maturity, but is expected to continue to grow as a result of the
aging Asia-Pacific population. BMP growth factor therapy was the fastest growing segment
in 2010, increasing almost 7% over the previous year.
This report provides a comprehensive and detailed analysis of market revenues by device
type, market forecasts through 2017, unit sales, average selling prices, market drivers and
limiters and a detailed competitive analysis, including manufacturer market shares and
product portfolios.
Latest Market Research Reports:
Latin American Markets for Spinal Implants and VCF 2011
U.S. Market for Women’s Health Devices 2011
Brazilian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,
Extraoral X-Ray Systems and CBCT Scanners)
Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,
Extraoral X-Ray Systems and CBCT Scanners)
Indian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,
Extraoral X-Ray Systems and CBCT Scanners)
Chinese Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,
Extraoral X-Ray Systems and CBCT Scanners)
U.S. Hyaluronic Acid Viscosupplementation Physician Survey 2011
International Hyaluronic Acid Viscosupplementation Physician Survey 2011
Production, Market and Benchmarking of Xanthan Gum in China

2. TABLE OF CONTENTS
TABLE OF CONTENTS.I
LIST OF FIGURESVIII
LIST OF CHARTS XVIII
EXECUTIVE SUMMARY. 1
1.1 TOTAL ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET. 1
1.2 HERFINDAHL INDEX COUNTRY PROFILES 2
1.3 GROWTH TRENDS BY MARKET SEGMENT 3
1.4 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS 4
1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET . 5
1.6 BONE MORPHOGENETIC PROTEIN MARKET . 6
1.7 COMPETITIVE ANALYSIS 7
RESEARCH METHODOLOGY. 8
2.1 RESEARCH SCOPE . 8
2.2 IDATA’S 9-STEP METHODOLOGY . 8
2.2.1 Step 1: Project Initiation & Team Selection 9
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research. 10
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design 11
2.2.4 Step 4: Performing Primary Research. 12
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 14
2.2.6 Step 6: Market Forecast and Analysis . 14
2.2.7 Step 7: Identify Strategic Opportunities 16
2.2.8 Step 8: Final Review and Market Release . 17
2.2.9 Step 9: Customer Feedback and Market Monitoring. 18
ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET 19
3.1 INTRODUCTION . 19
3.1.1 Growth Factors. 20
Table of Contents
3.1.2 Bone Graft Substitutes 20
3.1.3 Hyaluronic Acid Viscosupplementation 20
3.2 CURRENCY EXCHANGE RATES . 21
3.3 MARKET OVERVIEW. 22
3.4 MARKET BY SEGMENT 24
3.5 TREND ANALYSIS BY SEGMENT . 29
3.6 MARKET BY COUNTRY . 32
3.6.1 Total Market . 32
3.6.2 Japan. 37
3.6.3 China. 42
3.6.4 South Korea 47
3.6.5 Australia . 52
3.7 MARKET DRIVERS AND LIMITERS 57
3.7.1 Market Drivers 57
3.7.2 Market Limiters. 58
3.8 COMPETITIVE ANALYSIS 59

3. 3.8.1 Herfindahl Index . 64
3.9 MERGERS AND ACQUISITIONS 66
COUNTRY PROFILES 67
4.1 INTRODUCTION . 67
4.1.1 Population. 67
4.1.2 GDP per Capita 67
4.1.3 Price Index 67
4.2 JAPAN 68
4.3 CHINA . 69
4.4 SOUTH KOREA 70
4.5 AUSTRALIA . 71
PROCEDURE NUMBERS. 72
5.1 OVERVIEW 72
5.1.1 Total Orthopedic Bone Graft Substitute Procedures by Indication 72
5.1.2 Total Orthopedic Bone Graft Substitute Procedures by Segment. 76
5.1.3 Total Orthopedic Bone Graft Substitute Procedures by Country . 80
Table of Contents
BONE GRAFT SUBSTITUTE MARKET 84
6.1 INTRODUCTION . 84
6.1.1 Volumes Represented per Procedure 87
6.2 JAPAN 88
6.2.1 Market Analysis and Forecast 88
6.2.1.1 Volumes Represented per Procedure.88
6.2.1.2 Total Synthetic Market.89
6.2.1.3 Synthetic Spine Market 92
6.2.1.4 Synthetic Cervical Spine Market .95
6.2.1.5 Synthetic Thoracolumbar Spine Market 98
6.2.1.6 Synthetic Trauma and Reconstruction Market 101
6.2.1.7 Synthetic Craniomaxillofacial Market.104
6.2.2 Market Drivers and Limiters 107
6.2.2.1 Market Drivers.107
6.2.2.2 Market Limiters .107
6.2.3 Competitive Analysis. 109
6.3 CHINA . 112
6.3.1 Overview. 112
6.3.2 Market Analysis and Forecast 117
6.3.2.1 Total Allograft Market.117
6.3.2.2 Allograft Spine Market 120
6.3.2.3 Allograft Cervical Spine Market123
6.3.2.4 Allograft Thoracolumbar Spine Market 126
6.3.2.5 Allograft Trauma & Reconstruction Market .129
6.3.2.6 Allograft Craniomaxillofacial Market .132
6.3.2.7 Total Synthetic Market.135
6.3.2.8 Synthetic Spine Market 138
6.3.2.9 Synthetic Cervical Spine Market .141
6.3.2.10 Synthetic Thoracolumbar Spine Market 144
6.3.2.11 Synthetic Trauma & Reconstruction Market .147

4. 6.3.2.12 Synthetic Craniomaxillofacial Market.150
6.3.2.13 Total DBM Market.153
6.3.2.14 DBM Spine Market 156
Table of Contents
6.3.2.15 DBM Cervical Spine Market .159
6.3.2.16 DBM Thoracolumbar Spine Market 162
6.3.2.17 DBM Trauma & Reconstruction Market .165
6.3.2.18 DBM Craniomaxillofacial Market.168
6.3.3 Market Drivers and Limiters 171
6.3.3.1 Market Drivers.171
6.3.3.2 Market Limiters .171
6.3.4 Competitive Analysis. 173
6.4 SOUTH KOREA 176
6.4.1 Overview. 176
6.4.2 Market Analysis and Forecast 181
6.4.2.1 Total Allograft Market.181
6.4.2.2 Allograft Spine Market 184
6.4.2.3 Allograft Cervical Spine Market187
6.4.2.4 Allograft Thoracolumbar Spine Market 190
6.4.2.5 Allograft Trauma & Reconstruction Market .193
6.4.2.6 Allograft Craniomaxillofacial Market .196
6.4.2.7 Total Synthetic Market.199
6.4.2.8 Synthetic Spine Market 202
6.4.2.9 Synthetic Cervical Spine Market .205
6.4.2.10 Synthetic Thoracolumbar Spine Market 208
6.4.2.11 Synthetic Trauma & Reconstruction Market .211
6.4.2.12 Synthetic Craniomaxillofacial Market.214
6.4.2.13 Total Demineralized Bone Matrix Market.217
6.4.2.14 DBM Spine Market 220
6.4.2.15 DBM Cervical Spine Market .223
6.4.2.16 DBM Thoracolumbar Spine Market 226
6.4.2.17 DBM Trauma & Reconstruction Market .229
6.4.2.18 DBM Craniomaxillofacial Market.232
6.4.3 Market Drivers and Limiters 235
6.4.3.1 Market Drivers.235
6.4.3.2 Market Limiters .235
6.4.4 Competitive Analysis. 237
6.5 AUSTRALIA . 241
Table of Contents
6.5.1 Overview. 241
6.5.2 Market Analysis and Forecast 246
6.5.2.1 Total Allograft Market.246
6.5.2.2 Allograft Spine Market 250
6.5.2.3 Allograft Cervical Spine Market253
6.5.2.4 Allograft Thoracolumbar Spine Market 256
6.5.2.5 Allograft Trauma & Reconstruction Market .259
6.5.2.6 Allograft Craniomaxillofacial Market .262
6.5.2.7 Total Synthetic Market.265
6.5.2.8 Synthetic Spine Market 268

5. 6.5.2.9 Synthetic Cervical Spine Market .271
6.5.2.10 Synthetic Thoracolumbar Spine Market 274
6.5.2.11 Synthetic Trauma & Reconstruction Market .277
6.5.2.12 Synthetic Craniomaxillofacial Market.280
6.5.3 Market Drivers and Limiters 283
6.5.3.1 Market Drivers.283
6.5.3.2 Market Limiters .284
6.5.4 Competitive Analysis. 285
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY
MARKET 289
7.1 INTRODUCTION . 289
7.1.1 Overview. 289
7.1.2 Potential Complications . 290
7.2 AUSTRALIA . 291
7.2.1 Market Analysis and Forecast 291
7.2.1.1 Total BMP Market .291
7.2.2 Market Drivers and Limiters 294
7.2.2.1 Market Drivers.294
7.2.2.2 Market Limiters .295
7.2.3 Competitive Analysis. 297
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET . 299
8.1 INTRODUCTION . 299
Table of Contents
8.1.1.1 Single-Injection Products 300
8.1.1.2 Three-Injection Cycle Products.300
8.1.1.3 Five-Injection Cycle Products .300
8.2 JAPAN 301
8.2.1 Market Analysis and Forecast 301
8.2.1.1 Total Hyaluronic Acid Viscosupplementation Market.301
8.2.2 Market Drivers and Limiters 304
8.2.2.1 Market Drivers.304
8.2.2.2 Market Limiters .305
8.2.3 Competitive Analysis. 306
8.3 CHINA . 309
8.3.1 Market Analysis and Forecast 309
8.3.1.1 Total Hyaluronic Acid Viscosupplementation Market.309
8.3.2 Market Analysis and Forecast 314
8.3.2.1 Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market 314
8.3.2.2 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market 317
8.3.3 Market Drivers and Limiters 320
8.3.3.1 Market Drivers.320
8.3.3.2 Market Limiters .321
8.3.4 Competitive Analysis. 322
8.4 SOUTH KOREA 325
8.4.1 Overview. 325
8.4.2 Market Analysis and Forecast 330
8.4.2.1 Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market 330

6. 8.4.2.2 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market 333
8.4.3 Market Drivers and Limiters 336
8.4.3.1 Market Drivers.336
8.4.3.2 Market Limiters .337
8.4.4 Competitive Analysis. 338
8.5 AUSTRALIA . 341
8.5.1 Market Analysis and Forecast 341
8.5.2 Market Drivers and Limiters 344
8.5.2.1 Market Drivers.344
8.5.2.2 Market Limiters .344
Table of Contents
8.5.3 Competitive Analysis. 345
ABBREVIATIONS 347
APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY
WEIGHT. 348
APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION
MARKET 355
APPENDIX 3: EMERGING MARKETS . 358
12.1 BONE MORPHOGENETIC PROTEIN MARKET . 358
12.2 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 358
List of Figures
LIST OF FIGURES
EXECUTIVE SUMMARY 1
Figure 1-1: Total Orthopedic Biomaterials Market, Asia-Pacific, 2010 (US$M). 1
Figure 1-2: Herfindahl Index by Country, Asia-Pacific, 2010 . 2
Figure 1-3: Growth Trends, Orthopedic Biomaterials Market, Asia-Pacific, 2007
– 2017 . 3
Figure 1-4: Procedure Numbers, Bone Graft Substitute Market, Asia-Pacific,
2007 – 2017. 4
Figure 1-5: Growth Rates, Hyaluronic Acid Viscosupplementation Market,
Asia-Pacific, 2007 – 2017 5
Figure 1-6: Bone Morphogenetic Protein Market, Australia, 2007 – 2017 (US$M) . 6
Figure 1-7: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,
2010 7
RESEARCH METHODOLOGY 8
ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET . 19
Figure 3-1: Exchange Rate for Currencies, 2010 . 21
Figure 3-2: Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017 22
Figure 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific,
2007 – 2017 (US$M) . 25
Figure 3-4: Growth Rates by Segment, Orthopedic Biomaterials Market,
Asia-Pacific, 2007 – 2017 30
Figure 3-5: Orthopedic Biomaterials Market by Country, Asia-Pacific,
2007 – 2017 (US$M) . 33
Figure 3-6: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017
(US$M) . 38
Figure 3-7: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017

7. (JP¥M) 38
Figure 3-8: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017
(US$M) . 43
List of Figures
Figure 3-9: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017
(CN¥M). 43
Figure 3-10: Orthopedic Biomaterials Market by Segment, South Korea,
2007 – 2017 (US$M) . 48
Figure 3-11: Orthopedic Biomaterials Market by Segment, South Korea,
2007 – 2017 (KR₩M) 48
Figure 3-12: Orthopedic Biomaterials Market by Segment, Australia,
2007 – 2017 (US$M) . 53
Figure 3-13: Orthopedic Biomaterials Market by Segment, Australia,
2007 – 2017 (AU$M). 53
Figure 3-14: Drivers and Limiters, Orthopedic Biomaterials Market, Asia-Pacific,
2010 58
Figure 3-15: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,
2010 (1 of 2) . 61
Figure 3-16: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,
2010 (2 of 2) . 62
Figure 3-17: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010. 64
COUNTRY PROFILES 67
Figure 4-1: Country Indicators, Asia-Pacific, 2010 . 68
PROCEDURE NUMBERS 72
Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Asia-Pacific,
2007 – 2017. 73
Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment,
Asia-Pacific, 2007 – 2017 77
Figure 5-3: Total Orthopedic Bone Graft Substitute Procedures by Country,
Asia-Pacific, 2007 – 2017 81
BONE GRAFT SUBSTITUTE MARKET 84
Figure 6-1: Total Synthetic Market, Japan, 2007 – 2017 (US$) 90
Figure 6-2: Total Synthetic Market, Japan, 2007 – 2017 (JP¥) . 90
Figure 6-3: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$) 93
Figure 6-4: Synthetic Total Spine Market, Japan, 2007 – 2017 (JP¥) . 93
Figure 6-5: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$) . 96
Figure 6-6: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (JP¥) 96
Figure 6-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (US$) 99
List of Figures
Figure 6-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (JP¥) . 99
Figure 6-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017
(US$) 102
Figure 6-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017
(JP¥) . 102
Figure 6-11: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$). 105
Figure 6-12: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (JP¥) 105
Figure 6-13: Drivers and Limiters, Bone Graft Substitute Market, Japan, 2010 . 108
Figure 6-14: Leading Competitors, Bone Graft Substitute Market, Japan, 2010 . 110
Figure 6-15: Bone Graft Substitute Market by Segment, China, 2007 – 2017

8. (US$M) . 113
Figure 6-16: Bone Graft Substitute Market by Segment, China, 2007 – 2017
(CN¥M). 113
Figure 6-17: Total Allograft Market, China, 2007 – 2017 (US$) 118
Figure 6-18: Total Allograft Market, China, 2007 – 2017 (CN¥) . 118
Figure 6-19: Allograft Total Spine Market, China, 2007 – 2017 (US$) 121
Figure 6-20: Allograft Total Spine Market, China, 2007 – 2017 (CN¥) 121
Figure 6-21: Allograft Cervical Spine Market, China, 2007 – 2017 (US$) 124
Figure 6-22: Allograft Cervical Spine Market, China, 2007 – 2017 (CN¥) . 124
Figure 6-23: Allograft Thoracolumbar Spine Market, China, 2007 – 2017
(US$) 127
Figure 6-24: Allograft Thoracolumbar Spine Market, China, 2007 – 2017
(CN¥) 127
Figure 6-25: Allograft Trauma & Reconstruction Market, China, 2007 – 2017
(US$) 130
Figure 6-26: Allograft Trauma & Reconstruction Market, China, 2007 – 2017
(CN¥) 130
Figure 6-27: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (US$) 133
Figure 6-28: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (CN¥) 133
Figure 6-29: Total Synthetic Market, China, 2007 – 2017 (US$) . 136
Figure 6-30: Total Synthetic Market, China, 2007 – 2017 (CN¥) . 136
Figure 6-31: Synthetic Total Spine Market, China, 2007 – 2017 (US$) 139
Figure 6-32: Synthetic Total Spine Market, China, 2007 – 2017 (CN¥) 139
Figure 6-33: Synthetic Cervical Spine Market, China, 2007 – 2017 (US$) . 142
List of Figures
Figure 6-34: Synthetic Cervical Spine Market, China, 2007 – 2017 (CN¥) . 142
Figure 6-35: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017 (US$)145
Figure 6-36: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017
(CN¥) 145
Figure 6-37: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017
(US$) 148
Figure 6-38: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017
(CN¥) 148
Figure 6-39: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (US$) 151
Figure 6-40: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (CN¥) 151
Figure 6-41: Total DBM Market, China, 2007 – 2017 (US$) . 154
Figure 6-42: Total DBM Market, China, 2007 – 2017 (CN¥) . 154
Figure 6-43: DBM Total Spine Market, China, 2007 – 2017 (US$) 157
Figure 6-44: DBM Total Spine Market, China, 2007 – 2017 (CN¥) 157
Figure 6-45: DBM Cervical Spine Market, China, 2007 – 2017 (US$) . 160
Figure 6-46: DBM Cervical Spine Market, China, 2007 – 2017 (CN¥). 160
Figure 6-47: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (US$) . 163
Figure 6-48: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (CN¥). 163
Figure 6-49: DBM Trauma & Reconstruction Market, China, 2007 – 2017 (US$)166
Figure 6-50: DBM Trauma & Reconstruction Market, China, 2007 – 2017
(CN¥) 166
Figure 6-51: DBM Craniomaxillofacial Market, China, 2007 – 2017 (US$) . 169
Figure 6-52: DBM Craniomaxillofacial Market, China, 2007 – 2017 (CN¥) . 169
Figure 6-53: Drivers and Limiters, Bone Graft Substitute Market, China, 2010 172

9. Figure 6-54: Leading Competitors, Bone Graft Substitute Market, China, 2010 174
Figure 6-55: Bone Graft Substitute Market by Segment, South Korea,
2007 – 2017 (US$M) . 177
Figure 6-56: Bone Graft Substitute Market by Segment, South Korea,
2007 – 2017 (KR₩M) 177
Figure 6-57: Total Allograft Market, South Korea, 2007 – 2017 (US$) 182
Figure 6-58: Total Allograft Market, South Korea, 2007 – 2017 (KR₩) 182
Figure 6-59: Allograft Total Spine Market, South Korea, 2007 – 2017 (US$) 185
Figure 6-60: Allograft Total Spine Market, South Korea, 2007 – 2017 (KR₩). 185
List of Figures
Figure 6-61: Allograft Cervical Spine Market, South Korea, 2007 – 2017 (US$) 188
Figure 6-62: Allograft Cervical Spine Market, South Korea, 2007 – 2017
(KR₩) 188
Figure 6-63: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017
(US$) 191
Figure 6-64: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017
(KR₩) 191
Figure 6-65: Allograft Trauma & Reconstruction Market, South Korea,
2007 – 2017 (US$). 194
Figure 6-66: Allograft Trauma & Reconstruction Market, South Korea,
2007 – 2017 (KR₩) . 194
Figure 6-67: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017
(US$) 197
Figure 6-68: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017
(KR₩) 197
Figure 6-69: Total Synthetic Market, South Korea, 2007 – 2017 (US$) 200
Figure 6-70: Total Synthetic Market, South Korea, 2007 – 2017 (KR₩) 200
Figure 6-71: Synthetic Total Spine Market, South Korea, 2007 – 2017 (US$) 203
Figure 6-72: Synthetic Total Spine Market, South Korea, 2007 – 2017 (KR₩) 203
Figure 6-73: Synthetic Cervical Spine Market, South Korea, 2007 – 2017 (US$) 206
Figure 6-74: Synthetic Cervical Spine Market, South Korea, 2007 – 2017
(KR₩) 206
Figure 6-75: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017
(US$) 209
Figure 6-76: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017
(KR₩) 209
Figure 6-77: Synthetic Trauma & Reconstruction Market, South Korea,
2007 – 2017 (US$). 212
Figure 6-78: Synthetic Trauma & Reconstruction Market, South Korea,
2007 – 2017 (KR₩) . 212
Figure 6-79: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017
(US$) 215
List of Figures
Figure 6-80: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017
(KR₩) 215
Figure 6-81: Total DBM Market, South Korea, 2007 – 2017 (US$) 218
Figure 6-82: Total DBM Market, South Korea, 2007 – 2017 (KR₩) 218
Figure 6-83: DBM Total Spine Market, South Korea, 2007 – 2017 (US$) 221
Figure 6-84: DBM Total Spine Market, South Korea, 2007 – 2017 (KR₩) 221

10. Figure 6-85: DBM Cervical Spine Market, South Korea, 2007 – 2017 (US$) . 224
Figure 6-86: DBM Cervical Spine Market, South Korea, 2007 – 2017 (KR₩) 224
Figure 6-87: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017
(US$) 227
Figure 6-88: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017
(KR₩) 227
Figure 6-89: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017
(US$) 230
Figure 6-90: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017
(KR₩) 230
Figure 6-91: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017
(US$) 233
Figure 6-92: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017
(KR₩) 233
Figure 6-93: Drivers and Limiters, Bone Graft Substitute Market, South Korea,
2010 236
Figure 6-94: Leading Competitors, Bone Graft Substitute Market, South Korea,
2010 239
Figure 6-95: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017
(US$M) . 242
Figure 6-96: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017
(AU$M) 242
Figure 6-97: Total Allograft Market, Australia, 2007 – 2017 (US$) . 247
Figure 6-98: Total Allograft Market, Australia, 2007 – 2017 (AU$) 248
Figure 6-99: Allograft Total Spine Market, Australia, 2007 – 2017 (US$) . 251
Figure 6-100: Allograft Total Spine Market, Australia, 2007 – 2017 (AU$) . 251
Figure 6-101: Allograft Cervical Spine Market, Australia, 2007 – 2017 (US$) . 254
List of Figures
Figure 6-102: Allograft Cervical Spine Market, Australia, 2007 – 2017 (AU$) 254
Figure 6-103: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017
(US$) 257
Figure 6-104: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017
(AU$) . 257
Figure 6-105: Allograft Trauma & Reconstruction Market, Australia,
2007 – 2017 (US$). 260
Figure 6-106: Allograft Trauma & Reconstruction Market, Australia,
2007 – 2017 (AU$) 260
Figure 6-107: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017
(US$) 263
Figure 6-108: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017
(AU$) 263
Figure 6-109: Total Synthetic Market, Australia, 2007 – 2017 (US$). 266
Figure 6-110: Total Synthetic Market, Australia, 2007 – 2017 (AU$) 266
Figure 6-111: Synthetic Total Spine Market, Australia, 2007 – 2017 (US$) . 269
Figure 6-112: Synthetic Total Spine Market, Australia, 2007 – 2017 (AU$). 269
Figure 6-113: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (US$) 272
Figure 6-114: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (AU$) 272
Figure 6-115: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017
(US$) 275

11. Figure 6-116: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017
(AU$) . 275
Figure 6-117: Synthetic Trauma & Reconstruction Market, Australia,
2007 – 2017 (US$). 278
Figure 6-118: Synthetic Trauma & Reconstruction Market, Australia,
2007 – 2017 (AU$) 278
Figure 6-119: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017
(US$) 281
Figure 6-120: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017
(AU$) 281
Figure 6-121: Drivers and Limiters, Bone Graft Substitute Market, Australia,
2010 284
List of Figures
Figure 6-122: Leading Competitors, Bone Graft Substitute Market, Australia,
2010 287
Figure 6-123: Leading Competitors, Bone Graft Substitute Market, Australia,
2010 . 288
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY
MARKET 289
Figure 7-1: Bone Morphogenetic Market, Australia, 2007 – 2017 (US$) 292
Figure 7-2: Bone Morphogenetic Market, Australia, 2007 – 2017 (AU$) . 292
Figure 7-3: Drivers and Limiters, Bone Morphogenetic Protein Market, Australia,
2010 296
Figure 7-4: Leading Competitors, Bone Morphogenetic Protein Market, Australia,
2010 297
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET. 299
Figure 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017
(US$) 302
Figure 8-2: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017
(JP¥) . 302
Figure 8-3: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market,
Japan, 2010 . 305
Figure 8-4: Leading Competitors, Hyaluronic Acid Viscosupplementation
Market, Japan, 2010. 307
Figure 8-5: Total Hyaluronic Acid Viscosupplementation Market,. 310
Figure 8-6: Total Hyaluronic Acid Viscosupplementation Market, China,
2007 – 2017 (CN¥M) . 310
Figure 8-7: Three-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, China, 2007 – 2017 (US$) . 315
Figure 8-8: Three-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, China, 2007 – 2017 (CN¥). 315
Figure 8-9: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market,
China, 2007 – 2017 (US$) 318
Figure 8-10: Five-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, China, 2007 – 2017 (CN¥). 318
Figure 8-11: Drivers and Limiters, Hyaluronic Acid Viscosupplementation
Market, China, 2010 321
List of Figures
Figure 8-12: Leading Competitors, Hyaluronic Acid Viscosupplementation

12. Market, China, 2010 323
Figure 8-13: Total Hyaluronic Acid Viscosupplementation Market, South Korea,
2007 – 2017 (US$M) . 326
Figure 8-14: Total Hyaluronic Acid Viscosupplementation Market, South Korea,
2007 – 2017 (KR₩M) 326
Figure 8-15: Three-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, South Korea, 2007 – 2017 (US$) . 331
Figure 8-16: Three-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, South Korea, 2007 – 2017 (KR₩) . 331
Figure 8-17: Five-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, South Korea, 2007 – 2017 (US$) . 334
Figure 8-18: Five-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, South Korea, 2007 – 2017 (KR₩) . 334
Figure 8-19: Drivers and Limiters, Hyaluronic Acid Viscosupplementation
Market, South Korea, 2010 337
Figure 8-20: Leading Competitors, Hyaluronic Acid Viscosupplementation
Market, South Korea, 2010 339
Figure 8-21: Hyaluronic Acid Viscosupplementation Market, Australia,
2007 – 2017 (US$). 342
Figure 8-22: Hyaluronic Acid Viscosupplementation Market, Australia,
2007 – 2017 (AU$) 342
Figure 8-23: Drivers and Limiters, Hyaluronic Acid Viscosupplementation
Market, Australia, 2010 . 345
Figure 8-24: Leading Competitors, Hyaluronic Acid Viscosupplementation
Market, Australia, 2010 . 345
ABBREVIATIONS 347
APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY
WEIGHT . 348
Figure 10-1: Total Synthetic Market, Japan, 2007 – 2017 (US$) 349
Figure 10-2: Total Synthetic Market, Japan, 2007 – 2017 (JP¥) . 349
Figure 10-3: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$) 350
Figure 10-4: Synthetic Total Spine Market, Japan, 2007 – 2017 (JP¥) . 350
List of Figures
Figure 10-5: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$) 351
Figure 10-6: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (JP¥). 351
Figure 10-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017
(US$) 352
Figure 10-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017
(JP¥) . 352
Figure 10-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017
(US$) 353
Figure 10-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017
(JP¥) . 353
Figure 10-11: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$)354
Figure 10-12: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (JP¥) 354
APPENDIX 2: TAIWANESE HYALURONIC ACID
VISCOSUPPLEMENTATION MARKET . 355
Figure 11-1: Exchange Rate for Currencies, 2010 . 355
Figure 11-2: Hyaluronic Acid Viscosupplementation Market, Taiwan,

13. 2007 – 2017 (US$). 356
Figure 11-3: Hyaluronic Acid Viscosupplementation Market, Taiwan,
2007 – 2017 (TW$) 356
APPENDIX 3: EMERGING MARKETS . 358
List of Charts
LIST OF CHART S
EXECUTIVE SUMMARY 1
RESEARCH METHODOLOGY 8
ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET . 19
Chart 3-1: Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017 (US$M) 23
Chart 3-2: Orthopedic Biomaterials Market by Segment, Asia-Pacific,
2007 – 2017 (US$M) . 26
Chart 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2010 27
Chart 3-4: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2017 . 28
Chart 3-5: Growth Rates by Segment, Orthopedic Biomaterials Market,
Asia-Pacific, 2007 – 2017 31
Chart 3-6: Orthopedic Biomaterials Market by Country, Asia-Pacific,
2007 – 2017 (US$M) 34
Chart 3-7: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2010. 35
Chart 3-8: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2017. 36
Chart 3-9: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017
(US$M) . 39
Chart 3-10: Orthopedic Biomaterials Market by Segment, Japan, 2010 40
Chart 3-11: Orthopedic Biomaterials Market by Segment, Japan, 2017 41
Chart 3-12: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017
(US$M) . 44
Chart 3-13: Orthopedic Biomaterials Market by Segment, China, 2010 45
Chart 3-14: Orthopedic Biomaterials Market by Segment, China, 2017 46
Chart 3-15: Orthopedic Biomaterials Market by Segment, South Korea,
2007 – 2017 (US$M) . 49
Chart 3-16: Orthopedic Biomaterials Market by Segment, South Korea, 2010 50
Chart 3-17: Orthopedic Biomaterials Market by Segment, South Korea, 2017 51
Chart 3-18: Orthopedic Biomaterials Market by Segment, Australia, 2007 – 2017
(US$M) 54
Chart 3-19: Orthopedic Biomaterials Market by Segment, Australia, 2010. 55
List of Charts
Chart 3-20: Orthopedic Biomaterials Market by Segment, Australia, 2017. 56
Chart 3-21: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,
2010 63
Chart 3-22: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010 65
COUNTRY PROFILES 67
Chart 4-1: Country Profile, Japan, 2010 68
Chart 4-2: Country Profile, China, 2010 . 69
Chart 4-3: Country Profile, South Korea, 2010 70
Chart 4-4: Country Profile, Australia, 2010. 71
PROCEDURE NUMBERS 72
Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication,
Asia-Pacific, 2010 . 74

14. Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication,
Asia-Pacific, 2017 . 75
Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment,
Asia-Pacific, 2010 . 78
Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment,
Asia-Pacific, 2017 79
Chart 5-5: Total Orthopedic Bone Graft Substitute Procedures by Country,
Asia-Pacific, 2010 . 82
Chart 5-6: Total Orthopedic Bone Graft Substitute Procedures by Country,
Asia-Pacific, 2017 . 83
BONE GRAFT SUBSTITUTE MARKET 84
Chart 6-1: Total Synthetic Market, Japan, 2007 – 2017 (US$M) 91
Chart 6-2: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$M) 94
Chart 6-3: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$M) 97
Chart 6-4: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (US$M) 100
Chart 6-5: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017
(US$M) . 103
Chart 6-6: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$M) 106
Chart 6-7: Leading Competitors, Bone Graft Substitute Market, Japan, 2010 . 111
Chart 6-8: Bone Graft Substitute Market by Segment, China, 2007 – 2017
(US$M) . 114
Chart 6-9: Bone Graft Substitute Market by Segment, China, 2010 115
List of Charts
Chart 6-10: Bone Graft Substitute Market by Segment, China, 2017 116
Chart 6-11: Total Allograft Market, China, 2007 – 2017 (US$M) 119
Chart 6-12: Allograft Total Spine Market, China, 2007 – 2017 (US$M). 122
Chart 6-13: Allograft Cervical Spine Market, China, 2007 – 2017 (US$M) 125
Chart 6-14: Allograft Thoracolumbar Spine Market, China, 2007 – 2017
(US$M) . 128
Chart 6-15: Allograft Trauma & Reconstruction Market, China, 2007 – 2017
(US$M) . 131
Chart 6-16: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (US$M) 134
Chart 6-17: Total Synthetic Market, China, 2007 – 2017 (US$M) 137
Chart 6-18: Synthetic Total Spine Market, China, 2007 – 2017 (US$M) 140
Chart 6-19: Synthetic Cervical Spine Market, China, 2007 – 2017 (US$M) . 143
Chart 6-20: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017
(US$M) . 146
Chart 6-21: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017
(US$M) . 149
Chart 6-22: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (US$M) 152
Chart 6-23: Total DBM Market, China, 2007 – 2017 (US$M) 155
Chart 6-24: DBM Total Spine Market, China, 2007 – 2017 (US$M) 158
Chart 6-25: DBM Cervical Spine Market, China, 2007 – 2017 (US$M) . 161
Chart 6-26: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (US$M) . 164
Chart 6-27: DBM Trauma & Reconstruction Market, China, 2007 – 2017
(US$M) . 167
Chart 6-28: DBM Craniomaxillofacial Market, China, 2007 – 2017 (US$M) 170
Chart 6-29: Leading Competitors, Bone Graft Substitute Market, China, 2010 175
Chart 6-30: Bone Graft Substitute Market by Segment, South Korea, 2007 – 2017

15. (US$M) . 178
Chart 6-31: Bone Graft Substitute Market by Segment, South Korea, 2010 179
Chart 6-32: Bone Graft Substitute Market by Segment, South Korea, 2017 180
Chart 6-33: Total Allograft Market, South Korea, 2007 – 2017 (US$M) 183
Chart 6-34: Allograft Total Spine Market, South Korea, 2007 – 2017 (US$M). 186
Chart 6-35: Allograft Cervical Spine Market, South Korea, 2007 – 2017
(US$M) . 189
List of Charts
Chart 6-36: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017
(US$M) . 192
Chart 6-37: Allograft Trauma & Reconstruction Market, South Korea,
2007 – 2017 (US$M) . 195
Chart 6-38: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017
(US$M) . 198
Chart 6-39: Total Synthetic Market, South Korea, 2007 – 2017 (US$M) 201
Chart 6-40: Synthetic Total Spine Market, South Korea, 2007 – 2017 (US$M) 204
Chart 6-41: Synthetic Cervical Spine Market, South Korea, 2007 – 2017
(US$M) . 207
Chart 6-42: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017
(US$M) . 210
Chart 6-43: Synthetic Trauma & Reconstruction Market, South Korea,
2007 – 2017 (US$M) . 213
Chart 6-44: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017
(US$M) . 216
Chart 6-45: Total DBM Market, South Korea, 2007 – 2017 (US$M) 219
Chart 6-46: DBM Total Spine Market, South Korea, 2007 – 2017 (US$M) 222
Chart 6-47: DBM Cervical Spine Market, South Korea, 2007 – 2017 (US$M) 225
Chart 6-48: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017
(US$M) . 228
Chart 6-49: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017
(US$M) . 231
Chart 6-50: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017
(US$M) . 234
Chart 6-51: Leading Competitors, Bone Graft Substitute Market, South Korea,
2010 240
Chart 6-52: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017
(US$M) . 243
Chart 6-53:Bone Graft Substitute Market by Segment, Australia, 2010 244
Chart 6-54: Bone Graft Substitute Market by Segment, Australia, 2017 . 245
Chart 6-55: Total Allograft Market, Australia, 2007 – 2017 (US$M) . 249
Chart 6-56: Allograft Total Spine Market, Australia, 2007 – 2017 (US$M) 252
Chart 6-57: Allograft Cervical Spine Market, Australia, 2007 – 2017 (US$M) . 255
List of Charts
Chart 6-58: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017
(US$M) . 258
Chart 6-59: Allograft Trauma & Reconstruction Market, Australia, 2007 – 2017
(US$M) . 261
Chart 6-60: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017
(US$M) . 264

16. Chart 6-61: Total Synthetic Market, Australia, 2007 – 2017 (US$M). 267
Chart 6-62: Synthetic Total Spine Market, Australia, 2007 – 2017 (US$M) . 270
Chart 6-63: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (US$M) 273
Chart 6-64: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017
(US$M) . 276
Chart 6-65: Synthetic Trauma & Reconstruction Market, Australia, 2007 – 2017
(US$M) . 279
Chart 6-66: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017
(US$M) . 282
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY
MARKET 289
Chart 7-1: Bone Morphogenetic Market, Australia, 2007 – 2017 (US$M) 293
Chart 7-2: Leading Competitors, Bone Morphogenetic Protein Market, Australia,
2010 298
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET. 299
Chart 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017
(US$M) . 303
Chart 8-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market,
Japan, 2010 . 308
Chart 8-3: Total Hyaluronic Acid Viscosupplementation Market, China,
2007 – 2017 (US$M) . 311
Chart 8-4: Total Hyaluronic Acid Viscosupplementation Market, China, 2010 . 312
Chart 8-5: Total Hyaluronic Acid Viscosupplementation Market, China, 2017 . 313
Chart 8-6: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market,
China, 2007 – 2017 (US$M) 316
Chart 8-7: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market,
China, 2007 – 2017 (US$M) 319
List of Charts
Chart 8-8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market,
China, 2010 . 324
Chart 8-9: Total Hyaluronic Acid Viscosupplementation Market, South Korea,
2007 – 2017 (US$M) . 327
Chart 8-10: Total Hyaluronic Acid Viscosupplementation Market, South Korea,
2010 328
Chart 8-11: Total Hyaluronic Acid Viscosupplementation Market, South Korea,
2017 329
Chart 8-12: Three-Injection Cycle Hyaluronic Acid Viscosupplementation
Market, South Korea, 2007 – 2017 (US$M). 332
Chart 8-13: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market,
South Korea, 2007 – 2017 (US$M) 335
Chart 8-14: Leading Competitors, Hyaluronic Acid Viscosupplementation
Market, South Korea, 2010 . 340
Chart 8-15: Hyaluronic Acid Viscosupplementation Market, Australia, 2010 –
2017 (US$M). 343
Chart 8-16: Leading Competitors, Hyaluronic Acid Viscosupplementation
Market, Australia, 2010 . 346
ABBREVIATIONS 347
APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY
WEIGHT . 348

17. APPENDIX 2: TAIWANESE HYALURONIC ACID
VISCOSUPPLEMENTATION MARKET . 355
Chart 11-1: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 – 2017
(US$M) . 357
APPENDIX 3: EMERGING MARKETS . 358
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsnreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com